<DOC>
	<DOC>NCT01181544</DOC>
	<brief_summary>During hemodialysis treatments, patients receive heparin to prevent clotting. The purpose of this pilot study is to determine if the amount of heparin administered during a patient's hemodialysis can be individualized using an equation for heparin dose adjustment.</brief_summary>
	<brief_title>A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Adults 18 years of age or older Stable hemodialysis prescription prior to study enrollment Dialyzing through a native fistula or GoreTex graft Blood access must be able to provide a blood flow rate of 400 ml/min Noncompliance with dialysis Hematocrit less than 28% Active Infection Diagnosis of HeparinInduced Thrombocytopenia (HIT)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Anticoagulation</keyword>
	<keyword>Heparin</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Renal Dialysis</keyword>
</DOC>